The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
- PMID: 16868550
- DOI: 10.1038/nri1901
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
Abstract
Interleukin-2 and interleukin-15 have pivotal roles in the control of the life and death of lymphocytes. Although their heterotrimeric receptors have two receptor subunits in common, these two cytokines have contrasting roles in adaptive immune responses. The unique role of interleukin-2 is in the elimination of self-reactive T cells to prevent autoimmunity. By contrast, interleukin-15 is dedicated to the prolonged maintenance of memory T-cell responses to invading pathogens. As discussed in this Review, the biology of these cytokines will affect the development of novel therapies for malignancy and autoimmune diseases, as well as the design of vaccines against infectious diseases.
Similar articles
-
Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy.Immunity. 2001 Feb;14(2):105-10. Immunity. 2001. PMID: 11239443 Review. No abstract available.
-
[Biology and immunotherapy advance of interleukin 2 and interleukin 15-review].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Aug;17(4):1088-92. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 19698267 Review. Chinese.
-
The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy.Cancer Immunol Res. 2015 Mar;3(3):219-27. doi: 10.1158/2326-6066.CIR-15-0009. Cancer Immunol Res. 2015. PMID: 25736261 Free PMC article. Review.
-
IL-15 in the life and death of lymphocytes: immunotherapeutic implications.Trends Mol Med. 2003 Dec;9(12):517-21. doi: 10.1016/j.molmed.2003.10.005. Trends Mol Med. 2003. PMID: 14659465 Review. No abstract available.
-
The IL-2/IL-15 receptor systems: targets for immunotherapy.J Clin Immunol. 2002 Mar;22(2):51-6. doi: 10.1023/a:1014416616687. J Clin Immunol. 2002. PMID: 11998892 Review.
Cited by
-
Interleukin 15 Pharmacokinetics and Consumption by a Dynamic Cytokine Sink.Front Immunol. 2020 Aug 13;11:1813. doi: 10.3389/fimmu.2020.01813. eCollection 2020. Front Immunol. 2020. PMID: 32903632 Free PMC article. Review.
-
Practical NK cell phenotyping and variability in healthy adults.Immunol Res. 2015 Jul;62(3):341-56. doi: 10.1007/s12026-015-8664-y. Immunol Res. 2015. PMID: 26013798 Free PMC article.
-
Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells.Oncotarget. 2016 Nov 22;7(47):76793-76805. doi: 10.18632/oncotarget.12529. Oncotarget. 2016. PMID: 27732937 Free PMC article.
-
NK Cell-Targeted Immunotherapies in Bladder Cancer: Beyond Checkpoint Inhibitors.Bladder Cancer. 2023 Jun 27;9(2):125-139. doi: 10.3233/BLC-220109. eCollection 2023. Bladder Cancer. 2023. PMID: 38993289 Free PMC article. Review.
-
Interleukin-15 plays a central role in human kidney physiology and cancer through the γc signaling pathway.PLoS One. 2012;7(2):e31624. doi: 10.1371/journal.pone.0031624. Epub 2012 Feb 21. PLoS One. 2012. PMID: 22363690 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials